Extended evaluation of allergic bronchopulmonary aspergillosis

A. C. Ghory, R. Patterson, Paul Allen Greenberger, M. Roberts

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


The clinical status and laboratory findings of 19 patients with allergic bronchopulmonary aspergillosis (ABPA) elevated over a period ranging from 3 months to 10 years are reviewed (average 2.6 years). Criteria establishing the diagnosis of ABPA as well as an estimate of duration of ABPA prior to diagnosis in selected cases is presented. 10 of the 19 patients currently require chronic corticosteroids for control of asthma as compared to 4 patients at the time of initial diagnosis. 16 exacerbations of ABPA have occurred in 8 patients. There is no correlation between the severity of asthma and either the number of exacerbations or persistent radiographic stigmata of ABPA. Pulmonary function tests range from normal to obstructive and restrictive changes.

Original languageEnglish (US)
Pages (from-to)285-291
Number of pages7
JournalInternational Archives of Allergy and Applied Immunology
Issue number3
StatePublished - Jan 1 1980

ASJC Scopus subject areas

  • Immunology and Allergy


Dive into the research topics of 'Extended evaluation of allergic bronchopulmonary aspergillosis'. Together they form a unique fingerprint.

Cite this